Evidence map›Paper›PMID 42315507›Full record

ArticleOncogenesis2026

Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

A G Manente, D Valenti, G Pinton, P V Jithesh, A Daga, L Rossi, S G Gray, K J O'Byrne, D A Fennell, R A Vacca and 3 more

Abstract readExpression of Concern
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

A G ManenteDepartment Pharmaceutical Sciences, University of Piemonte Orientale 'A. Avogadro', Novara, Italy.
D ValentiCNR-IBBE, Bari, Italy.
G PintonDepartment Pharmaceutical Sciences, University of Piemonte Orientale 'A. Avogadro', Novara, Italy.
P V JitheshLiverpool Cancer Research UK Centre, University of Liverpool, Liverpool, UK.
A DagaIRCCS San Martino-IST, Genova, Italy.
L RossiDepartment of Human Morphology and Applied Biology, University of Pisa, Pisa, Italy.
S G GrayInstitute of Molecular Medicine, St James's Hospital, Dublin, Ireland.
K J O'ByrneInstitute of Molecular Medicine, St James's Hospital, Dublin, Ireland.
D A FennellMRC Toxicology Unit, University of Leicester and Leicester University Hospitals, Leicester, UK.
R A VaccaCNR-IBBE, Bari, Italy.
S NilssonKaro Bio AB, Huddinge, Sweden.
L MuttiDepartment of Medicine, S. Andrea Hospital, Vercelli, Italy.
L MoroDepartment Pharmaceutical Sciences, University of Piemonte Orientale 'A. Avogadro', Novara, Italy. moro@pharm.unipmn.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42315507
PMCPMC13279950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.